Total medical devices industry M&A deals worth $831.84m were announced in the US in February 2021, with Veracyte’s $600m acquisition of Decipher Biosciences being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 96.2% over the previous month of $22.04bn and a drop of 87.9% when compared with the last 12-month average of $6.9bn.
The US held a 96.52% share of the global medical devices industry M&A deal value that totalled $861.84m in February 2021.
In terms of M&A deal activity, the US recorded 28 deals during February 2021, marking a decrease of 12.50% over the previous month and a rise of 33.33% over the 12-month average.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataUS medical devices industry M&A deals in February 2021: Top deals
The top five medical devices industry M&A deals accounted for 99.6% of the overall value during February 2021.
The combined value of the top five medical devices M&A deals stood at $828.34m, against the overall value of $831.84m recorded for the month.
The top five medical devices industry M&A deals of February 2021 tracked by GlobalData were:
1) Veracyte’s $600m acquisition of Decipher Biosciences
2) The $150m acquisition of Simplify Medical by NuVasive
3) Mind Medicine MindMed’ $32.66m acquisition of HealthMode.
4) The $23.68m acquisition of Chronix Biomedical by OncoCyte
5) Volpara Solutions’ acquisition of CRA Health for $22m.
